Genomic medicine and cancer clinical trial in Thailand.
作者信息
Thamlikitkul Lucksamon, Parinyanitikul Napa, Sriuranpong Virote
机构信息
Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University & The King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
出版信息
Cancer Biol Med. 2023 Aug 23;21(1):10-5. doi: 10.20892/j.issn.2095-3941.2023.0175.
Abstract
摘要
相似文献
1
Genomic medicine and cancer clinical trial in Thailand.泰国的基因组医学与癌症临床试验。
Cancer Biol Med. 2023 Aug 23;21(1):10-5. doi: 10.20892/j.issn.2095-3941.2023.0175.
2
[The National Cancer Professional Council and the Cancer Genomic Medicine Subcommittee].[国家癌症专业委员会与癌症基因组医学小组委员会]
Gan To Kagaku Ryoho. 2022 Sep;49(9):989-990.
3
[Issues of Equalization of Cancer Genomic Medicine-Focusing on the Current Status in Nagasaki Prefecture].[癌症基因组医学的公平化问题——以长崎县的现状为重点]
Gan To Kagaku Ryoho. 2022 Sep;49(9):1005-1007.
4
[Additional Remarks on the Issue of Cancer Genomic Medicine-Regarding Regional Disparity and Exit Strategies].[关于癌症基因组医学问题的补充说明——关于地区差异和退出策略]
Gan To Kagaku Ryoho. 2022 Sep;49(9):1008-1010.
5
[Multidisciplinary Collaboration and Education Program Required for Equalization of Cancer Genomic Medicine].[癌症基因组医学均衡化所需的多学科协作与教育计划]
Gan To Kagaku Ryoho. 2022 Sep;49(9):1002-1004.
6
[Expert Panel Issues in Japan].[日本的专家小组问题]
Gan To Kagaku Ryoho. 2022 Sep;49(9):991-993.
7
[Additional Remarks on the Issue of Cancer Genomic Medicine-Focusing on Medical Insurance Issues].[关于癌症基因组医学问题的补充说明——聚焦医疗保险问题]
Gan To Kagaku Ryoho. 2022 Sep;49(9):1011-1013.
8
[Panel Discussion - Problems in the Cancer Genomic Medicine].[小组讨论 - 癌症基因组医学中的问题]
Gan To Kagaku Ryoho. 2022 Sep;49(9):1014-1017.
9
Guidelines for Handling of Cytological Specimens in Cancer Genomic Medicine.癌症基因组医学中细胞学标本处理指南。
Pathobiology. 2023;90(5):289-311. doi: 10.1159/000528346. Epub 2023 Feb 8.
10
[Overview of Clinical Application of Whole Genome Analysis for Cancer].[癌症全基因组分析的临床应用概述]
Gan To Kagaku Ryoho. 2024 Jan;51(1):7-13.
引用本文的文献
1
Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data Generation, Main Hurdles, and Future Perspectives.变革个性化医疗：与多组学数据生成的协同作用、主要障碍及未来展望
Biomedicines. 2024 Nov 30;12(12):2750. doi: 10.3390/biomedicines12122750.
本文引用的文献
1
Expanding the Reach and Grasp of Lung Cancer Screening.扩大肺癌筛查的范围和影响力。
Am Soc Clin Oncol Educ Book. 2023 Jan;43:e389958. doi: 10.1200/EDBK_389958.
2
Lung adenocarcinoma promotion by air pollutants.空气污染促进肺腺癌。
Nature. 2023 Apr;616(7955):159-167. doi: 10.1038/s41586-023-05874-3. Epub 2023 Apr 5.
3
Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study.ChAdOx1-nCoV-19疫苗在实体恶性肿瘤患者中按治疗方案与健康对照相比的免疫原性：一项前瞻性、多中心观察性研究。
EClinicalMedicine. 2022 Oct;52:101608. doi: 10.1016/j.eclinm.2022.101608. Epub 2022 Aug 11.
4
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations.针对具有致癌驱动分子改变的肺癌患者的靶向治疗。
J Clin Oncol. 2022 Feb 20;40(6):611-625. doi: 10.1200/JCO.21.01626. Epub 2022 Jan 5.
5
Association between family history and lung cancer risk among Chinese women in Singapore.新加坡华裔女性的家族史与肺癌风险之间的关联。
Sci Rep. 2021 Nov 8;11(1):21862. doi: 10.1038/s41598-021-00929-9.
6
Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study.多西他赛与尼达尼布联合治疗泰国晚期非小细胞肺癌的疗效：一项多中心研究
Front Oncol. 2021 Apr 29;11:572740. doi: 10.3389/fonc.2021.572740. eCollection 2021.
7
Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing.符合 NCCN 乳腺癌/卵巢癌遗传评估标准的泰国患者中，生殖系癌症易感性基因突变的发生率很高：对亚洲人群检测的意义。
Breast Cancer Res Treat. 2021 Jul;188(1):237-248. doi: 10.1007/s10549-021-06152-4. Epub 2021 Mar 1.
8
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
9
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.用于转移性癌症患者的下一代测序（NGS）的推荐意见：来自 ESMO 精准医学工作组的报告。
Ann Oncol. 2020 Nov;31(11):1491-1505. doi: 10.1016/j.annonc.2020.07.014. Epub 2020 Aug 24.
10
Constituents of Household Air Pollution and Risk of Lung Cancer among Never-Smoking Women in Xuanwei and Fuyuan, China.家庭空气污染成分与中国宣威和富源不吸烟女性肺癌风险。
Environ Health Perspect. 2019 Sep;127(9):97001. doi: 10.1289/EHP4913. Epub 2019 Sep 5.
Zotero 插件